Medco Health Solutions MHS posted an in-line Q4 and did not raise guidance, Jefferies reports.
“Expect stock to trade flat or down on this news,” Jefferies writes.
“MHS reported in-line adjusted 4Q10 EPS of $0.94 on revenues of
$16.9B, EBITDA of $786.7MM and EBITDA/adjusted claim of $3.22
(vs. consensus of $3.26).”
Medco Health Solutions currently trades at $38.48.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in